FDA Approves the First RSV Vaccine for Pregnant Women
The US Food and Drug Administration (FDA) today (Aug. 21) approved the first vaccine for respiratory syncytial virus (RSV) for pregnant women, which is designed to protect newborns from the infection. The shot becomes the second RSV vaccine, and third new intervention against the disease this year. In May, the FDA approved the Abrysvo vaccine … Read more